Revium Rx RVRC
OTC RVRC
$1.43 +0.00 (+0.00%)
At close: Oct 20, 2026 · 4:00 PM EDT

Revium Rx (RVRC) Other Non-Current Liabilities (2025 - 2026)

Updated

Revium Rx (RVRC) recorded Other Non-Current Liabilities of $575,000 in Q2 2026.

Analysis

Revium Rx (RVRC) Other Non-Current Liabilities (2025 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,170.58 Bn 1,139.17 Bn 19.71 Bn
2 Johnson & Johnson 645.51 Bn 565.37 Bn 17.30 Bn
3 AbbVie 502.28 Bn 475.39 Bn 12.70 Bn
4 Merck 363.81 Bn 318.18 Bn 12.21 Bn
5 Novartis Ag 302.62 Bn 266.61 Bn 11.24 Bn
6 Astrazeneca 268.13 Bn 241.81 Bn 12.86 Bn
7 Amgen 242.20 Bn 197.60 Bn 7.24 Bn
8 Gilead Sciences 193.87 Bn 168.07 Bn 6.22 Bn
9 Pfizer 172.06 Bn 118.71 Bn 10.94 Bn
10 Revium Rx 86.84 Mn 86.00 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 575,000.00
Dec 31, 2025 575,000.00
API Access

Revium Rx Other Non-Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=RVRC&period=max&api_key=YOUR_API_KEY